Rare diseases
Investigational molecules
Locations
Back to France868 clinical trials in Rennes, France across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)FrancePhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
FranceA Phase 3 Randomized Study of mRNA‑4157 plus Pembrolizumab as Adjuvant Therapy in Patients with Completely Resected Stage I Non‑Small Cell Lung Cancer
FranceOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
FranceStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
FranceStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
FrancePhase III Randomized Study of Rilvegostomig vs. Pembrolizumab with Platinum-based Chemotherapy in PD-L1 Expressing Metastatic Squamous NSCLC
FranceStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
FranceA Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma
FranceA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
FranceA Study to Test if Rinvecalinase Alfa is Safe and Works for Treating Acute Ischemic Stroke in Patients with Moderate Stroke Severity
FranceStudy of nadofaragene firadenovec alone or with gemcitabine, docetaxel or pembrolizumab in adults with non-muscle invasive bladder cancer who did not respond to BCG therapy
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancers, breast cancer, and hematologic malignancies. Studies are evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Multiple research centers are investigating breakthrough treatments for various stages of cancer progression.
Comprehensive research into multiple sclerosis and movement disorders, utilizing advanced imaging techniques and innovative therapeutic approaches.
Studies are focused on improving patient outcomes through targeted interventions and precision medicine approaches.
Investigating new approaches in postoperative care and immunotherapy for critical care patients, with emphasis on patient comfort and infection prevention.
Research aims to enhance recovery outcomes and reduce complications in intensive care settings.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
